Skip Navigation

We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Chetan Bettegowda, M.D., Ph.D.

Headshot of Chetan Bettegowda
  • Jennison and Novak Families Professor of Neurosurgery
  • Professor of Neurosurgery
Male

Languages: English, Kannada

Expertise

Brain Tumors, CyberKnife and Stereotactic Radiosurgery, Gliomas, Meningiomas, Metastatic Brain Tumors, Neurosurgery, Pituitary Tumors, Skull Base Surgery, Skull Base Tumors, Spinal Cord Tumors, Spinal Tumors, Stereotactic Radiosurgery, Trigeminal Neuralgia, Von Hippel-Lindau (VHL) ...read more

Research Interests

Identify key genetic pathways that are altered in brain tumors; Developing clinical trials to selectively target these pathways; Developing targeted therapies for patients with primary and metastatic tumors of the brain and spine; Ongoing clinical protocol to develop a simple blood test that can detect and monitor disease burden in patients with tumors affecting the central nervous system ...read more

Request an Appointment

Insurance Information

Main Phone

410-955-8620

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-8620
600 N. Wolfe Street
Phipps Building, Suite 118
Baltimore, MD 21287 map
Phone: 410-955-8620 | Fax: 410-955-8534

Johns Hopkins Outpatient Center

Appointment Phone: 410-955-8620
601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-955-8620 | Fax: 410-955-8534

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-8620
10753 Falls Road
Pavilion II, Suite 115
Lutherville, MD 21093 map

Background

Dr. Chetan Bettegowda offers comprehensive treatments for adult patients with benign and malignant brain tumors, specializing in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors. He performs both open surgery and stereotactic radiosurgery for patients with metastatic tumors to the brain, and also provides stereotactic radiosurgery for other neurological disorders, including spinal tumors, trigeminal neuralgia and skull-base tumors.

...read more

Titles

  • Jennison and Novak Families Professor of Neurosurgery
  • Director, Meningioma Center
  • Co-Director, Trigeminal Neuralgia Center
  • Professor of Neurosurgery
  • Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD PhD; Johns Hopkins University School of Medicine (2005)

Residencies

  • Neurological Surgery; Johns Hopkins University School of Medicine (2012)

Board Certifications

  • American Board of Neurological Surgery (Neurological Surgery) (2017)

Research & Publications

Research Summary

Bringing personalized medicine to the forefront of treatment for patients with brain and spinal tumors is of specific interest to Dr. Chetan Bettegowda. His research is dedicated to developing targeted therapies for patients with primary and metastatic tumors of the brain and spine. As part of this research, he has helped identify key genetic pathways that are altered in brain tumors, and he is developing clinical trials to selectively target these pathways. Dr. Bettegowda is also spearheading an ongoing clinical protocol to develop a simple blood test that can detect and monitor disease burden in patients with tumors affecting the central nervous system

Clinical Trial Keywords

Ongoing clinical protocol to develop a simple blood test that can detect and monitor disease burden in patients with tumors affecting the central nervous system

Clinical Trials

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma. IRB Number: IRB00079861.


This study plans to test overall survival in patients treated with the medication Toca 511 (vocimagene amiretrorepvec), combined with Toca FC (flucytosine) tablets. This combination medication is being used to test to see if it works well for treating high grade gliomas patients whom have suffered a recurrence of their tumor


Learn more.

Activities & Honors

Honors

  • Burroughs Wellcome Career Award for Medical Scientists
  • Sanford Larson Award for Best Peripheral Nerve/Spine Paper, AANS
  • Clinician Scientist Award, Johns Hopkins
  • Grant, Pediatric Brain Tumor Foundation
  • Grant , American Association of Neurological Surgeons

Videos & Media

  • Play Video:

    Trigeminal Neuralgia Surgery: Q&A

  • Play Video:

    Trigeminal Neuralgia Surgery: What You Need to Know

  • Play Video:

    Trigeminal Neuralgia Surgery | Michelle's Story

  • Play Video:

    Malignant Brain Tumor Surgery - What You Need to Know

  • Play Video:

    Malignant Brain Tumor Clinical Trials - What You Need to Know

  • Play Video:

    Doorways to Discovery: Liquid Biopsy to Track Cancer

Recent News Articles and Media Coverage

Individualized Care Through Translocation Testing, NeuroLogic (Winter 2021)

After Brain Surgery, Hampton University's Reeana Richarson is Better than Ever. Daily Press (30 October 2017)

A Liquid Biopsy to Track Cancer and Avoid Surgery, Doorways to Discovery (November 2014)

Tumor Tracker, Hopkins Medicine Magazine, Spring/Summer 2014

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button